Las Vegas, NV -- (SBWIRE) -- 10/24/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies, China Marine Food Group Ltd (NYSEMKT:CMFO), Repros Therapeutics Inc (NASDAQ:RPRX), Delcath Systems, Inc (NASDAQ:DCTH), Datalink Corporation (NASDAQ:DTLK)
China Marine Food Group Ltd (NYSEMKT:CMFO) was a volume gainer of 3.29 million shares and the average volume of the stock remained 158,490 shares. The stock opened the session at $0.18 and finished at the end of the day at $0.190 and the stock plunged -68.33%.The market capitalization of the stock remained 5.65 million. The half-yearly trend of the stock remained negative -75.98%. China Marine Food Group Limited, is engaged in the business of processing, distribution and sale of processed seafood-based snack foods, as well as the sale of fresh and frozen marine catch. The Company is a holding company whose primary business operations are conducted through its direct, wholly owned subsidiary, Ocean Technology (China) Company Limited (Ocean Technology) and its subsidiaries, Shishi Rixiang Marine Food Co., Ltd. (Rixiang), Shishi Huabao Jixiang Water Products Co., Ltd.(Jixiang), Shishi Huabao Mingxiang Foods Co., Ltd. (Mingxiang) and Shishi Xianglin Trading Co., Ltd. (Xianglin).
Has CMFO Found The Bottom and Ready To Move Up? Find Out Here
In the preceding trading session, Repros Therapeutics Inc (NASDAQ:RPRX) exchanged 4.79 million shares and the average volume remained 892,469 shares. The stock closed the session at $17.12 with the drop of -27.73%. Tracking three months and 6 months trends, the stock was at of -16.08% and -15.62%, respectively. Repros Therapeutics, Inc. is a United States-based company that develops products and services for the management of reproductive health. The Company's products include: contraceptives, vaccines for prostate cancer, enhanced topical treatment for genital herpes as well as treatments for male and female sexual dysfunction. It focuses on the development of oral small molecule drugs to address major unmet medical needs in male and female health.
Has RPRX Found The Bottom And Ready To Gain Momentum? Find Out Here
Delcath Systems, Inc (NASDAQ:DCTH) decreased -24.52% and its closing price was $0.317. The volume of the stock was 8.99 million shares and the average volume remained 4.17 million shares. Yesterday, the stock traded amid the day price range of $0.31 - $0.34. The market capitalization of the stock remained 32.19 million. The beta of the stock remained 1.91. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system.
Why Should Investors Buy DCTH After the Recent Fall? Just Go Here and Find Out
Datalink Corporation (NASDAQ:DTLK) exchanged 1.69 million shares in the previous trading session, and its average trading remained 112,561 shares. DTLK dropped -23.79% and it closed the trading at $10.86. The market capitalization of the stock remained 241.06 million. YTD trend of the stock was negative -31.48%. Datalink Corporation designs, deploys, manages, and supports infrastructures, such as servers, storage and networks. The Company provides solutions and services. The Company leverages hardware and software from the original equipment manufacturers (OEMs) as part of its data center optimization offerings. The Company's portfolio of solutions and services spans four practices: consolidation and virtualization, data storage and protection, advanced network infrastructures, and business continuity and disaster recovery solutions.
Will DTLK Get Buyers Even After The Recent Rally? Find Out Here
About:Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock readers, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wallstreet. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)